» Articles » PMID: 26014584

Brain Metabolomics in Rats After Administration of Ketamine

Overview
Publisher Wiley
Specialties Biology
Chemistry
Date 2015 May 28
PMID 26014584
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, we developed a brain metabolomic method, based on gas chromatography-mass spectrometry (GC/MS), to evaluate the effect of ketamine on rats. Pattern recognition analysis, including both principal component analysis and partial least squares-discriminate analysis revealed that ketamine induced metabolic perturbations. Compared with the control group, the levels of glycerol, uridine, cholesterol in rat brain of the ketamine group (50 mg/kg, 14 days) decreased, while the urea levels increased. Our results indicate that metabolomic methods based on GC/MS may be useful to elucidate ketamine abuse through the exploration of biomarkers.

Citing Articles

Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration.

Moaddel R, Zanos P, Farmer C, Kadriu B, Morris P, Lovett J Transl Psychiatry. 2022; 12(1):179.

PMID: 35501309 PMC: 9061764. DOI: 10.1038/s41398-022-01941-x.


Metabolism and metabolomics of ketamine: a toxicological approach.

Dinis-Oliveira R Forensic Sci Res. 2018; 2(1):2-10.

PMID: 30483613 PMC: 6197107. DOI: 10.1080/20961790.2017.1285219.


Linezolid Inhibited Synthesis of ATP in Mitochondria: Based on GC-MS Metabolomics and HPLC Method.

Ye X, Huang A, Wang X, Wen C, Hu L, Lin G Biomed Res Int. 2018; 2018:3128270.

PMID: 30410924 PMC: 6206563. DOI: 10.1155/2018/3128270.


Pharmacokinetic Interaction Study of Ketamine and Rhynchophylline in Rat Plasma by Ultra-Performance Liquid Chromatography Tandem Mass Spectrometry.

Chen L, You W, Chen D, Cai Y, Wang X, Wen C Biomed Res Int. 2018; 2018:6562309.

PMID: 29951541 PMC: 5989277. DOI: 10.1155/2018/6562309.


Prophylactic ketamine alters nucleotide and neurotransmitter metabolism in brain and plasma following stress.

McGowan J, Hill C, Mastrodonato A, LaGamma C, Kitayev A, Brachman R Neuropsychopharmacology. 2018; 43(9):1813-1821.

PMID: 29599484 PMC: 6046049. DOI: 10.1038/s41386-018-0043-7.